Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1

Oncogene volume 21, pages 3199–3206 (2002)Cite this article

Abstract

The p27Kip1 is a member of the universal cyclin-dependent kinase inhibitor family. Previously, immunochemical analysis of a series of breast cancer cell lines demonstrated a correlation between the expression of p27Kip1 and the breast cancer susceptibility gene BRCA1. BRCA1 has a number of activities including DNA repair, growth inhibition and as a transcription factor. Here we demonstrate that BRCA1 transactivates expression of p27Kip1. This transactivation is dependent on the presence of a functional C-terminal transactivation domain. Promoter-deletion analysis identified the presence of a putative BRCA1-responsive element located at position −615 to −511 of the p27Kip1 promoter. These results suggest that the transcriptional regulation of p27Kip1 by BRCA1 may be a mechanism for BRCA1- induced growth inhibition.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Abbott DW, Thompson ME, Robinson-Benoit C, Tomlinson G, Jensen RA, Holt JT . 1999 J. Biol. Chem. 274: 18808–18812

  • Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET . 1999 Proc. Natl. Acad. Sci. USA 96: 11866–11871

  • Callebaut I, Mornon JP . 1997 FEBS Lett. 400: 25–30

  • Catzevalos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Marave-Protzner I, Kapuska L, Franssen E, Pritchard KI, Slingerland JM . 1997 Nat. Med. 3: 227–230

  • Chapman MS, Verma IM . 1996 Nature 382: 678–679

  • Chappuis PO, Kapusta L, Begin LR, Wong N, Brunet J-S, Narod SA, Slingerland J, Foulkes WD . 2000 J. Clin. Oncol. 18: 4045–4052

  • Chen Y, Lee WH, Chew HK . 1999 J. Cell. Physiol. 181: 385–392

  • Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Moriden T, Rotterdam H, Weinstein IB . 1998 Cancer Res. 58: 114–122

  • Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzan M, Zhang Z-F, Massague J, Scher HI . 1998 J. Natl. Cancer Inst. 90: 1284–1291

  • Durana B, Gao FB, Raff M . 1997 EMBO J. 16: 306–317

  • Fero ML, Rande IE, Gurley KE, Roberts JM, Kemp CJ . 1998 Nature 396: 177–180

  • Elstner E, Williamson EA, Zang C, Fritz J, Heber D, Possinger K, Koeffler HP . 2002 Breast Cancer Res. Treat in press

  • Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshmann K, Tavtigan S, Bennet LM, Haugen-Strano A, Swenson J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R . 1994 Science 266: 120–122

  • Haile DT, Parvin JD . 1999 J. Biol. Chem. 274: 2113–2117

  • Halligan BD, Teng M, Guillams TG, Nauert JB, Halligan NL . 1995 Gene 161: 217–222

  • Houvras Y, Benezra M, Zhang H, Manfredi JJ, Weber BL, Licht J . 2000 J. Biol. Chem. 275: 36230–36237

  • Hu Y-F, Miyake T, Ye Q, Li R . 2000 J. Biol. Chem. 275: 40910–40915

  • Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace Jr AJ, Zhan Q . 2000 Oncogene 19: 4050–4057

  • Katayose Y, Kim M, Rakkar RNS, Li Z, Cowan KH, Seth P . 1997 Cancer Res. 57: 5441–5445

  • Koonin EV, Altschul SF, Bork P . 1996 Nat. Genet. 13: 266–268

  • Kwon TK, Nagel JE, Buchholz MA, Nordin AA . 1996 Gene 180: 113–120

  • Masciullo V, Sgamboto A, Pacilio C, Pucci B, Ferrandina G, Palazzo J, Carbone A, Cittadini A, Mancuso S, Schambia G, Giordano A . 1999 Cancer Res. 59: 3790–3794

  • Medema RH, Kops GJP, Bos JL, Burgering BMT . 2000 Nature 404: 782–787

  • Minami S, Ohtani-Fujita N, Igata E, Tamaki S, Sakai T . 1997 FEBS Lett. 411: 1–6

  • Niwa Y, Oyama T, Nakajima T . 2000 Jpn. J. Cancer Res. 91: 519–526

  • Onishi T, Hruska K . 1997 Endocrinology 138: 1995–2004

  • Ouchi T, Monteiro A, August A, Aaronson SA, Hanafusa H . 1998 Proc. Natl. Acad. Sci. USA 95: 2302–2306

  • Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A . 1994 Genes Dev. 8: 9–22

  • Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM . 1997 Cell 88: 265–275

  • Sherr CJ . 1994 Cell 79: 551–555

  • Sherr CJ, Roberts JM . 1999 Genes Dev. 13: 1501–1512

  • Somasundaram K, Zhang H, Zeng Y-X, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El-Deiry WS . 1997 Nature 389: 187–190

  • Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP . 1996 Cancer Res. 56: 2400–2404

  • St. Croix B, Florenes VA, Rak JW, Flanagan M, Bhattacharya N, Slingerland JM, Kerbel RS . 1996 Nat. Med. 2: 1204–1210

  • Tomlinson GE, Chen TT-L, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minni JD, Gazdar AF . 1998 Cancer Res. 58: 3237–3242

  • Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R . 1996 Nat. Genet. 14: 430–440

  • Yamane K, Katayama E, Tsuruo T . 2000 Biochem. Biophys. Res. Commun. 279: 678–684

  • Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, Weber BL, El-Deiry WS . 1998 Oncogene 16: 1713–1721

Download references

Acknowledgements

We thank B Weber, J Holt, J Wyke and T Sakai for the BRCA1 and p27Kip1 promoter constructs. EA Williamson is a recipient of a Postdoctoral Fellowship from the California Breast Cancer Research Program. HP Koeffler holds the endowed Mark Goodsen Chair of Oncology and is a member of the Jonsson Cancer Center. This work was supported by the Ko-So Foundation and the Parker Hughes Trust. We are grateful for the generous support of Norma Thorworth's Fund.

Author information

Authors and Affiliations

  1. Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, 90048, California CA, USA

    Elizabeth A Williamson & H Phillip Koeffler

  2. Department of Anatomic Pathology, Cedars-Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, 90048, California, CA, USA

    Farnaz Dadmanesh

Authors
  1. Elizabeth A Williamson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farnaz Dadmanesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Phillip Koeffler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth A Williamson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williamson, E., Dadmanesh, F. & Koeffler, H. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1. Oncogene 21, 3199–3206 (2002). https://doi.org/10.1038/sj.onc.1205461

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205461

Keywords

This article is cited by

Search

Advanced search

Quick links